ArticleBMC infectious diseases2026
Parvovirus B19-induced aplastic crises in children with hereditary spherocytosis in the Czech Republic: multicentre retrospective study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHereditary spherocytosis is the most common congenital anaemia in Europe. In patients with this disease, parvovirus B19 infection leads to aplastic crisis - a severe complication with significant morbidity and decrease in haemoglobin concentration and reticulocyte count.
methodsThis retrospective, multicentre study, conducted at the Department of Paediatrics, Faculty of Medicine and Dentistry Palacký University and University Hospital Olomouc, and the Department of Paediatric Haematology and Biochemistry, University Hospital Brno, Czech Republic, aims to describe the clinical features, diagnostic approaches, complications, and treatment of parvovirus B19-induced aplastic crises in paediatric patients with a diagnosis of hereditary spherocytosis between January 1 and June 30, 2024.
resultsA total of 23 patients with a confirmed diagnosis of hereditary spherocytosis were hospitalised due to parvovirus B19-induced aplastic crisis. Their mean age was 6.9 years. The most frequent clinical symptoms were fever (p-value < 0.0001), pallor (p-value < 0.0001), fatigue (p-value 0.0001), vomiting (p-value 0.001), pain (p-value 0.004), and cough (p-value 0.009). Erythema infectiosum was rare. A mean haemoglobin concentration was 4.93 g/dL (range from 2.9 to 7.4 g/dL). Other abnormal haematological parameters included leukopenia (26.0%), thrombocytopenia (8.7%), or pancytopenia (26.0%). Mean transfusion requirements were 2.74 transfusion units of red blood cells. There was no significant difference between men and women in age, haemoglobin level, and number of transfusion units.
conclusionThis study provides a frequency of multiple clinical symptoms of parvovirus B19-induced aplastic crises in children with hereditary spherocytosis during an epidemic, together with haematological parameters and transfusion requirements. Beginning in January 2024, we have observed more Parvovirus B19 aplastic crises than expected. Similar increase of incidence of parvovirus B19-induced aplastic crises incidence has been reported across Europe and North America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.